Trade Health Catalyst - HCAT CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.09 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026207% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003985% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Health Catalyst Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 7.66 |
Open* | 7.62 |
1-Year Change* | -28.65% |
Day's Range* | 7.6 - 7.81 |
52 wk Range | 6.60-15.87 |
Average Volume (10 days) | 589.69K |
Average Volume (3 months) | 9.95M |
Market Cap | 433.93M |
P/E Ratio | -100.00K |
Shares Outstanding | 57.55M |
Revenue | 290.02M |
EPS | -2.23 |
Dividend (Yield %) | N/A |
Beta | 1.32 |
Next Earnings Date | Feb 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 7, 2023 | 7.66 | 0.24 | 3.23% | 7.42 | 7.86 | 7.30 |
Dec 6, 2023 | 7.67 | 0.18 | 2.40% | 7.49 | 7.91 | 7.47 |
Dec 5, 2023 | 7.46 | 0.01 | 0.13% | 7.45 | 7.59 | 7.35 |
Dec 4, 2023 | 7.67 | 0.20 | 2.68% | 7.47 | 7.73 | 7.35 |
Dec 1, 2023 | 7.57 | 0.43 | 6.02% | 7.14 | 7.62 | 7.02 |
Nov 30, 2023 | 7.13 | -0.24 | -3.26% | 7.37 | 7.45 | 7.12 |
Nov 29, 2023 | 7.34 | -0.11 | -1.48% | 7.45 | 7.74 | 7.33 |
Nov 28, 2023 | 7.37 | 0.10 | 1.38% | 7.27 | 7.50 | 7.27 |
Nov 27, 2023 | 7.39 | -0.10 | -1.34% | 7.49 | 7.57 | 7.39 |
Nov 24, 2023 | 7.57 | -0.02 | -0.26% | 7.59 | 7.84 | 7.57 |
Nov 22, 2023 | 7.68 | 0.14 | 1.86% | 7.54 | 7.78 | 7.50 |
Nov 21, 2023 | 7.49 | -0.02 | -0.27% | 7.51 | 7.80 | 7.48 |
Nov 20, 2023 | 7.70 | -0.03 | -0.39% | 7.73 | 7.94 | 7.65 |
Nov 17, 2023 | 7.75 | -0.11 | -1.40% | 7.86 | 7.98 | 7.68 |
Nov 16, 2023 | 7.81 | -0.14 | -1.76% | 7.95 | 7.97 | 7.69 |
Nov 15, 2023 | 7.98 | -0.12 | -1.48% | 8.10 | 8.48 | 7.95 |
Nov 14, 2023 | 8.29 | 0.63 | 8.22% | 7.66 | 8.33 | 7.66 |
Nov 13, 2023 | 7.33 | 0.41 | 5.92% | 6.92 | 7.59 | 6.81 |
Nov 10, 2023 | 6.66 | -0.24 | -3.48% | 6.90 | 6.90 | 6.56 |
Nov 9, 2023 | 6.86 | -0.46 | -6.28% | 7.32 | 7.32 | 6.80 |
Health Catalyst Events
Time (UTC) | Country | Event |
---|---|---|
Monday, February 26, 2024 | ||
Time (UTC) 21:00 | Country US
| Event Q4 2023 Health Catalyst Inc Earnings Release Q4 2023 Health Catalyst Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 276.236 | 241.926 | 188.845 | 154.941 | 112.574 |
Revenue | 276.236 | 241.926 | 188.845 | 154.941 | 112.574 |
Cost of Revenue, Total | 142.043 | 124.166 | 98.077 | 74.069 | 59.852 |
Gross Profit | 134.193 | 117.76 | 90.768 | 80.872 | 52.722 |
Total Operating Expense | 416.241 | 385.576 | 293.484 | 211.476 | 172.669 |
Selling/General/Admin. Expenses, Total | 148.372 | 134.121 | 97.893 | 79.859 | 66.813 |
Research & Development | 72.635 | 61.832 | 53.517 | 46.22 | 38.592 |
Depreciation / Amortization | 48.3 | 37.5 | 18.8 | 9.2 | 7.412 |
Operating Income | -140.005 | -143.65 | -104.639 | -56.535 | -60.095 |
Interest Income (Expense), Net Non-Operating | -1.552 | -16.482 | -11.622 | -3.451 | -2.024 |
Net Income Before Taxes | -141.683 | -160.108 | -116.211 | -59.954 | -62.119 |
Net Income After Taxes | -137.403 | -153.21 | -115.017 | -60.096 | -61.984 |
Net Income Before Extra. Items | -137.403 | -153.21 | -115.017 | -60.096 | -61.984 |
Net Income | -137.403 | -153.21 | -115.017 | -60.096 | -61.984 |
Total Adjustments to Net Income | 0 | 0 | -180.826 | -52.037 | |
Income Available to Common Excl. Extra. Items | -137.403 | -153.21 | -115.017 | -240.922 | -114.021 |
Income Available to Common Incl. Extra. Items | -137.403 | -153.21 | -115.017 | -240.922 | -114.021 |
Diluted Net Income | -137.403 | -153.21 | -115.017 | -240.922 | -114.021 |
Diluted Weighted Average Shares | 53.722 | 47.495 | 39.541 | 18.741 | 35.0782 |
Diluted EPS Excluding Extraordinary Items | -2.55767 | -3.22581 | -2.9088 | -12.8553 | -3.25048 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Diluted Normalized EPS | -2.4525 | -2.81895 | -2.72495 | -12.7819 | -3.25048 |
Unusual Expense (Income) | 4.894 | 27.929 | 11.184 | 2.116 | |
Other Operating Expenses, Total | -0.003 | 0.028 | 14.013 | 0.012 | |
Other, Net | -0.126 | 0.024 | 0.05 | 0.032 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 73.213 | 73.868 | 69.162 | 68.354 | 70.633 |
Revenue | 73.213 | 73.868 | 69.162 | 68.354 | 70.633 |
Cost of Revenue, Total | 39.266 | 37.686 | 37.876 | 36.123 | 34.373 |
Gross Profit | 33.947 | 36.182 | 31.286 | 32.231 | 36.26 |
Total Operating Expense | 107.831 | 108.782 | 105.907 | 114.075 | 103.825 |
Selling/General/Admin. Expenses, Total | 27.668 | 29.3 | 35.734 | 42.211 | 35.152 |
Research & Development | 17.395 | 16.602 | 18.927 | 20.077 | 17.041 |
Depreciation / Amortization | 10.7 | 10.994 | 11.7 | 12.4 | 12.612 |
Unusual Expense (Income) | 12.767 | 14.2 | 1.706 | 3.292 | 4.647 |
Other Operating Expenses, Total | 0.035 | -0.036 | -0.028 | ||
Operating Income | -34.618 | -34.914 | -36.745 | -45.721 | -33.192 |
Interest Income (Expense), Net Non-Operating | 2.084 | 1.788 | 1.047 | 0.165 | -1.133 |
Other, Net | 0.006 | 0.005 | -0.025 | -0.023 | -0.047 |
Net Income Before Taxes | -32.528 | -33.121 | -35.723 | -45.579 | -34.372 |
Net Income After Taxes | -32.613 | -33.19 | -35.782 | -45.735 | -33.428 |
Net Income Before Extra. Items | -32.613 | -33.19 | -35.782 | -45.735 | -33.428 |
Net Income | -32.613 | -33.19 | -35.782 | -45.735 | -33.428 |
Income Available to Common Excl. Extra. Items | -32.613 | -33.19 | -35.782 | -45.735 | -33.428 |
Income Available to Common Incl. Extra. Items | -32.613 | -33.19 | -35.782 | -45.735 | -33.428 |
Diluted Net Income | -32.613 | -33.19 | -35.782 | -45.735 | -33.428 |
Diluted Weighted Average Shares | 55.977 | 55.485 | 53.887 | 54.304 | 53.675 |
Diluted EPS Excluding Extraordinary Items | -0.58261 | -0.59818 | -0.66402 | -0.8422 | -0.62279 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.43437 | -0.43183 | -0.64226 | -0.75851 | -0.56651 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 427.795 | 508.391 | 329.799 | 264.239 | 66.858 |
Cash and Short Term Investments | 363.49 | 444.981 | 270.871 | 228.277 | 33.192 |
Cash & Equivalents | 116.312 | 193.227 | 91.954 | 18.032 | 28.431 |
Short Term Investments | 247.178 | 251.754 | 178.917 | 210.245 | 4.761 |
Total Receivables, Net | 47.97 | 48.801 | 48.296 | 27.57 | 27.696 |
Accounts Receivable - Trade, Net | 47.97 | 48.801 | 48.296 | 27.57 | 27.696 |
Prepaid Expenses | 16.335 | 14.609 | 10.632 | 7.455 | 5.321 |
Other Current Assets, Total | 0.937 | 0.649 | |||
Total Assets | 752.286 | 832.096 | 577.74 | 302.36 | 110.975 |
Property/Plant/Equipment, Total - Net | 42.586 | 44.449 | 37.592 | 8.082 | 11.02 |
Property/Plant/Equipment, Total - Gross | 60.043 | 55.882 | 47.601 | 17.877 | 18.714 |
Accumulated Depreciation, Total | -17.457 | -11.433 | -10.009 | -9.795 | -7.694 |
Goodwill, Net | 185.982 | 169.972 | 107.822 | 3.694 | 3.694 |
Intangibles, Net | 92.189 | 104.788 | 98.921 | 25.535 | 28.304 |
Other Long Term Assets, Total | 3.734 | 4.496 | 3.606 | 0.81 | 1.099 |
Total Current Liabilities | 82.51 | 93.051 | 88.036 | 48.217 | 41.806 |
Accounts Payable | 4.424 | 4.693 | 5.332 | 3.622 | 1.812 |
Accrued Expenses | 23.125 | 27.15 | 19.132 | 11.75 | 11.78 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 1.287 | ||
Other Current Liabilities, Total | 54.961 | 61.208 | 63.572 | 32.845 | 26.927 |
Total Liabilities | 327.276 | 309.998 | 301.641 | 101.716 | 75.898 |
Total Long Term Debt | 226.523 | 180.942 | 168.994 | 48.2 | 18.814 |
Long Term Debt | 226.523 | 180.942 | 168.994 | 48.2 | 18.814 |
Other Liabilities, Total | 18.243 | 36.005 | 44.611 | 5.299 | 15.278 |
Total Equity | 425.01 | 522.098 | 276.099 | 200.644 | 35.077 |
Redeemable Preferred Stock | 0 | 409.845 | |||
Common Stock | 0.055 | 0.053 | 0.043 | 0.037 | 0.01 |
Additional Paid-In Capital | 1424.63 | 1400.97 | 1001.65 | 811.049 | 0 |
Retained Earnings (Accumulated Deficit) | -999.023 | -878.86 | -725.65 | -610.514 | -374.777 |
Other Equity, Total | -0.648 | -0.067 | 0.061 | 0.072 | -0.001 |
Total Liabilities & Shareholders’ Equity | 752.286 | 832.096 | 577.74 | 302.36 | 110.975 |
Total Common Shares Outstanding | 55.2619 | 52.6221 | 43.3769 | 36.6788 | 35.0782 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 408.453 | 410.951 | 434.517 | 427.795 | 443.45 |
Cash and Short Term Investments | 347.697 | 343.829 | 356.927 | 363.49 | 380.142 |
Cash & Equivalents | 94.971 | 115.689 | 133.479 | 116.312 | 124.224 |
Short Term Investments | 252.726 | 228.14 | 223.448 | 247.178 | 255.918 |
Total Receivables, Net | 46.085 | 52.378 | 61.862 | 47.97 | 49.544 |
Accounts Receivable - Trade, Net | 46.085 | 52.378 | 61.862 | 47.97 | 49.544 |
Prepaid Expenses | 12.571 | 12.644 | 15.728 | 16.335 | 13.764 |
Total Assets | 712.92 | 722.903 | 752.301 | 752.286 | 776.2 |
Property/Plant/Equipment, Total - Net | 41.373 | 41.846 | 42.602 | 42.586 | 42.296 |
Property/Plant/Equipment, Total - Gross | 66.05 | 63.969 | 61.735 | 60.043 | 60.779 |
Accumulated Depreciation, Total | -24.677 | -22.123 | -19.133 | -17.457 | -18.483 |
Goodwill, Net | 185.982 | 185.982 | 185.982 | 185.982 | 185.982 |
Intangibles, Net | 71.996 | 79.041 | 84.41 | 92.189 | 100.653 |
Other Long Term Assets, Total | 5.116 | 5.083 | 4.79 | 3.734 | 3.819 |
Total Current Liabilities | 84.253 | 86.759 | 102.495 | 82.51 | 91.066 |
Accounts Payable | 6.327 | 7.974 | 9.243 | 4.424 | 6.816 |
Accrued Expenses | 24.859 | 19.259 | 27.347 | 23.125 | 27.869 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | |||||
Other Current Liabilities, Total | 53.067 | 59.526 | 65.905 | 54.961 | 56.381 |
Total Liabilities | 330.526 | 333.036 | 347.155 | 327.276 | 336.234 |
Total Long Term Debt | 227.655 | 227.277 | 226.9 | 226.523 | 226.147 |
Long Term Debt | 227.655 | 227.277 | 226.9 | 226.523 | 226.147 |
Other Liabilities, Total | 18.618 | 19 | 17.76 | 18.243 | 19.021 |
Total Equity | 382.394 | 389.867 | 405.146 | 425.01 | 439.966 |
Common Stock | 0.057 | 0.056 | 0.056 | 0.055 | 0.054 |
Additional Paid-In Capital | 1469.36 | 1454.84 | 1437.6 | 1424.63 | 1404.03 |
Retained Earnings (Accumulated Deficit) | -1086.86 | -1064.83 | -1032.21 | -999.023 | -963.241 |
Other Equity, Total | -0.17 | -0.204 | -0.295 | -0.648 | -0.879 |
Total Liabilities & Shareholders’ Equity | 712.92 | 722.903 | 752.301 | 752.286 | 776.2 |
Total Common Shares Outstanding | 57.0441 | 56.5416 | 55.8435 | 55.2619 | 54.2138 |
Other Current Assets, Total | 2.1 | 2.1 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -137.403 | -153.21 | -115.017 | -60.096 | -61.984 |
Cash From Operating Activities | -35.27 | -23.123 | -26.148 | -32.184 | -40.296 |
Cash From Operating Activities | 48.297 | 37.528 | 18.725 | 9.212 | 7.412 |
Non-Cash Items | 72.266 | 95.077 | 75.244 | 22.483 | 0.583 |
Cash Taxes Paid | 0.297 | 0.138 | 0.092 | 0.019 | 0.031 |
Cash Interest Paid | 5.75 | 6.36 | 4.979 | 5.557 | 3.937 |
Changes in Working Capital | -13.907 | 4.616 | -3.827 | -3.823 | 13.693 |
Cash From Investing Activities | -39.021 | -139.678 | -82.565 | -209.602 | 21.403 |
Capital Expenditures | -17.414 | -18.467 | -10.465 | -4.334 | -2.503 |
Other Investing Cash Flow Items, Total | -21.607 | -121.211 | -72.1 | -205.268 | 23.906 |
Cash From Financing Activities | -2.613 | 264.084 | 182.609 | 231.381 | 24.346 |
Financing Cash Flow Items | -1.342 | -6.29 | -1.624 | 40.846 | -3.974 |
Issuance (Retirement) of Stock, Net | -1.271 | 270.374 | 40.537 | 212.356 | 28.32 |
Net Change in Cash | -76.915 | 101.273 | 73.922 | -10.399 | 5.453 |
Deferred Taxes | -4.523 | -7.134 | -1.273 | 0.04 | |
Issuance (Retirement) of Debt, Net | 0 | 0 | 143.696 | -21.821 | |
Foreign Exchange Effects | -0.011 | -0.01 | 0.026 | 0.006 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -33.19 | -137.403 | -101.621 | -55.886 | -22.458 |
Cash From Operating Activities | -5.58 | -35.27 | -20.449 | -8.418 | 1.158 |
Cash From Operating Activities | 10.994 | 48.297 | 36.633 | 24.261 | 11.649 |
Deferred Taxes | 0.002 | -4.523 | -4.527 | -4.529 | -3.598 |
Non-Cash Items | 14.579 | 72.266 | 53.982 | 31.142 | 10.697 |
Changes in Working Capital | 2.035 | -13.907 | -4.916 | -3.406 | 4.868 |
Cash From Investing Activities | 22.649 | -39.021 | -45.277 | -12.095 | 1.656 |
Capital Expenditures | -3.387 | -17.414 | -13.093 | -8.882 | -4.08 |
Other Investing Cash Flow Items, Total | 26.036 | -21.607 | -32.184 | -3.213 | 5.736 |
Cash From Financing Activities | 0.093 | -2.613 | -3.25 | 4.289 | 2.388 |
Financing Cash Flow Items | 0 | -1.342 | -1.342 | -0.93 | -0.93 |
Issuance (Retirement) of Stock, Net | 0.093 | -1.271 | -1.908 | 5.219 | 3.318 |
Foreign Exchange Effects | 0.005 | -0.011 | -0.027 | -0.02 | -0.001 |
Net Change in Cash | 17.167 | -76.915 | -69.003 | -16.244 | 5.201 |
Issuance (Retirement) of Debt, Net | 0 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.1531 | 6353184 | 164371 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.6892 | 3810399 | -8903 | 2023-06-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 5.269 | 3001410 | 162941 | 2023-06-30 | LOW |
Point72 Asset Management, L.P. | Hedge Fund | 4.9579 | 2824198 | 426942 | 2023-07-26 | HIGH |
First Light Asset Management, LLC | Investment Advisor/Hedge Fund | 4.4607 | 2540959 | 560642 | 2023-06-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 3.1477 | 1793019 | 248254 | 2023-06-30 | LOW |
Daventry Group, LP | Investment Advisor | 2.874 | 1637111 | 0 | 2023-06-30 | MED |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 2.4907 | 1418763 | 22860 | 2023-06-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.1147 | 1204624 | 428942 | 2023-06-30 | LOW |
Granahan Investment Management, Inc. | Investment Advisor | 2.0368 | 1160225 | 165388 | 2023-06-30 | LOW |
Impax Asset Management LLC | Investment Advisor | 2.0267 | 1154475 | -50000 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9833 | 1129740 | 48489 | 2023-06-30 | LOW |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 1.9015 | 1083177 | -199662 | 2023-06-30 | MED |
Goldman Sachs Asset Management, L.P. | Investment Advisor | 1.8638 | 1061691 | -216137 | 2023-06-30 | LOW |
Rock Springs Capital Management LP | Hedge Fund | 1.6324 | 929900 | 0 | 2023-06-30 | LOW |
Nepsis, Inc. | Investment Advisor | 1.5901 | 905804 | 63065 | 2023-09-30 | LOW |
Alyeska Investment Group, L.P. | Hedge Fund | 1.5765 | 898014 | 150644 | 2023-06-30 | HIGH |
Bares Capital Management, Inc. | Investment Advisor | 1.3693 | 780000 | 330000 | 2023-06-30 | LOW |
Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 1.3599 | 774640 | 60200 | 2023-06-30 | LOW |
Burton (Daniel D) | Individual Investor | 1.2932 | 736647 | -7103 | 2023-09-01 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Health Catalyst Company profile
About Health Catalyst Inc
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company operates in two segments: technology and professional services. The technology segment includes its data platform, analytics applications and support services. Its solution consists of a cloud-based data platform, analytics software and professional services expertise. Its cloud-based data operating system (DOS) is a healthcare-specific, open, flexible, and scalable data platform that provides customers with a single comprehensive environment to integrate and organize data from its software systems, which enables a range of analytics. Its software analytics application is built on top of its data platform to provide foundational or domain-specific insights that improve customers clinical, financial and operational performance. Its support services consist of both analytics experts and domain experts.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Health Catalyst Inc revenues increased 28% to $241.9M. Net loss increased 33% to $153.2M. Revenues reflect Technology segment increase of 34% to $147.7M, Professional Services segment increase of 20% to $94.2M. Higher net loss reflects Acquisition transaction costs increase from $2.7M to $26.2M (expense), Total Amort of Intangibles-excl Goodwill increase from $15.9M to $32M (expense).
Industry: | Application Software |
10897 South River Front Parkway, #300
SOUTH JORDAN
UTAH 84095
US
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com